Press "esc" to clear
Go to Advanced Search

Showing results

9893198940 of 103829
  • Embargo expired:
    1-Nov-1999 12:00 AM EST

Article ID: 15705

Combined Treatment Benefits Head and Neck Cancer Patients

American Society for Radiation Oncology (ASTRO)

Adding weekly chemotherapy to radiation therapy dramatically increases survival rates of some patients with advanced head and neck cancer, according to a new study presented at the American Society for Therapeutic Radiology annual in San Antonio.

Released:
2-Nov-1999 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    1-Nov-1999 12:00 AM EST

Article ID: 15703

Radiation Unblocks Clogged Arteries

American Society for Radiation Oncology (ASTRO)

In what could be a major breakthrough in the treatment of patients with cardiovascular disease, radiation treatments are now being used to keep once-blocked arteries from re-blocking. The study was presented at the American Society for Therapeutic Radiology annual meeting in San Antonio.

Released:
2-Nov-1999 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    1-Nov-1999 12:00 AM EST

Article ID: 15701

Smoking Impacts Potency of Prostate Cancer Patients

American Society for Radiation Oncology (ASTRO)

Prostate cancer patients who smoke might want to quit. A survey of patients treated with radiation therapy for the disease found that none of those who smoked were potent six years after treatment compared to about two-thirds of patients who were non-smokers. The survey was presented at the American Society for Therapeutic Radiology annual meeting in San Antonio.

Released:
2-Nov-1999 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    1-Nov-1999 12:00 AM EST

Article ID: 15700

Radiosurgery Preserves Hearing in Acoustic Neuroma Patients

American Society for Radiation Oncology (ASTRO)

Lower doses of radiation, combined with a technique called stereotactic radiosurgery, can preserve hearing, avoid damage to facial nerves and successfully treat acoustic neuromas, according to a new study presented at the American Society for Therapeutic Radiology annual meeting in San Antonio.

Released:
2-Nov-1999 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    1-Nov-1999 12:00 AM EST

Article ID: 15699

Increased Radiation Doses Benefit Some Prostate Cancer Patients

American Society for Radiation Oncology (ASTRO)

Prostate cancer patients who have disease locally confined to the prostate and who have PSA levels greater than ten before treatment dramatically benefit from higher doses of radiation, according to a new study presented at the American Society for Therapeutic Radiology annual meeting in San Antonio.

Released:
2-Nov-1999 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    1-Nov-1999 12:00 AM EST

Article ID: 15698

Neutron/Photon Radiation for Prostate Cancer

American Society for Radiation Oncology (ASTRO)

Mixing neutrons and photons as the types of radiation used to treat cancer confined to the prostate results in a 90 percent three-year disease free survival rate, according to a new study presented at the American Society for Therapeutic Radiology annual meeting in San Antonio.

Released:
2-Nov-1999 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    1-Nov-1999 12:00 AM EST

Article ID: 15697

IMRT Accurately Delivers Radiation to Prostate Cancer

American Society for Radiation Oncology (ASTRO)

Intensity modulated radiation therapy is a safe way to accurately deliver high doses of radiation to the prostate while preserving normal tissue nearby, a new study shows. The study was presented at the American Society for Therapeutic Radiology annual meeting October 31 - November 4, 1999 in San Antonio, TX.

Released:
2-Nov-1999 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    1-Nov-1999 12:00 AM EST

Article ID: 15696

Amifostine for Head and Neck Cancer Patients

American Society for Radiation Oncology (ASTRO)

A new drug is proving to be effective in treating one of the most common side effects patients suffer during and after radiation treatments for head and neck cancer. The drug, amifostine, is easing xerostomia (severe dry mouth), a condition that can make it very difficult for these patients to eat, drink and even speak. The study was presented at the American Society for Therapeutic Radiology annual meeting October 31 - November 4, 1999 in San Antonio, TX.

Released:
2-Nov-1999 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 15936

Consume Less Trans Fat, more Vitamin B6 and B12

University of Illinois at Urbana-Champaign

Eat less trans fat and more foods rich in magnesium, B6 and B12, says a professor emeritus of food chemistry at the University of Illinois.

Released:
30-Oct-1999 12:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 15931

Mentally Ill Under-Protected by Medical Privacy Rule

American Psychiatric Association (APA)

Today the American Psychiatric Association responded to President Clinton's proposed medical records privacy regulations by calling on the Administration to strengthen mental health patients' rights to secure, private medical records.

Released:
30-Oct-1999 12:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

9893198940 of 103829





Chat now!